These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 7907872

  • 1. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y.
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, Nakashima M, Uematsu T.
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [Abstract] [Full Text] [Related]

  • 3. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 4. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T, Matsumoto S, Hatoyama T, Miyazaki H.
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [Abstract] [Full Text] [Related]

  • 5. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
    Fujii T, Tanaka K, Matsumoto S, Hatoyama T, Nomura N, Tagawa M, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
    [Abstract] [Full Text] [Related]

  • 6. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, Rhodes G.
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ, Preston RA, Swan SK.
    Clin Pharmacokinet; 2007 Mar; 46(6):525-34. PubMed ID: 17518511
    [Abstract] [Full Text] [Related]

  • 8. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
    Tamai I, Kido Y, Yamashita J, Sai Y, Tsuji A.
    J Drug Target; 2000 Mar; 8(6):383-93. PubMed ID: 11328664
    [Abstract] [Full Text] [Related]

  • 9. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J, Schoemaker HC, Bruno R, Reinhoudt JF, Breimer DD, Cohen AF.
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of ebastine in children.
    Simons FE, Watson WT, Simons KJ.
    J Pediatr; 1993 Apr; 122(4):641-6. PubMed ID: 8096545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J, Liminana R, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H, Sugimoto T, Ago M, Morino A.
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.